Lv3
380 积分 2023-07-14 加入
Trial of the Oral PCSK9 Inhibitor Enlicitide
1个月前
已完结
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR
1个月前
已完结
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
1个月前
已完结
New Oral PCSK9 Inhibitor: “MK-0616”
1个月前
已完结
Dual Ablation of Grb10 and Grb14 in Mice Reveals Their Combined Role in Regulation of Insulin Signaling and Glucose Homeostasis
3个月前
已完结
Tirzepatide, a dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β‐cells and hepatic steatosis in obese type 2 diabetic db/db mice
3个月前
已完结
The global burden of COPD: epidemiology and effect of prevention strategies
3个月前
已完结
Inhalable nucleic acid therapeutics for chronic pulmonary disease: Progress, challenges, and prospects
3个月前
已完结
Synthesis of novel EGCG-glucose conjugates and studies of their antioxidative properties for neuroprotections
6个月前
已完结
Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes
6个月前
已完结
皖公网安备34019202002308
